SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-030192
Filing Date
2024-09-27
Accepted
2024-09-27 16:34:50
Documents
17
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pbla20240927_8k.htm   iXBRL 8-K 26857
2 EXHIBIT 10.1 ex_728016.htm EX-10.1 11975
3 EXHIBIT 10.2 ex_728017.htm EX-10.2 11158
8 logo01.jpg GRAPHIC 8243
  Complete submission text file 0001437749-24-030192.txt   189476

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240923.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240923_def.xml EX-101.DEF 10353
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240923_lab.xml EX-101.LAB 13836
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240923_pre.xml EX-101.PRE 10348
19 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240927_8k_htm.xml XML 2553
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39468 | Film No.: 241335413
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)